Tags: Drug.
Epoetin alfa (rINN) /ɛˈpoʊ.ɨtɨn/ is human erythropoietin produced in cell culture using recombinant DNA technology. Authorised by the European Medicines Agency on 28 August 2007 it stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen. Its annual cost to U.S.